Efficacy and safety of basal insulin plus glucagon-like peptide-1 receptor agonist versus basal-bolus insulin in type 2 diabetes: A systematic review and meta-analysis of randomised controlled trials

被引：0
|
作者：
Acharya, Y. [1 ]
Tangney, N. [2 ]
Lim, J. L. [3 ]
O'Brien, T. [1 ,3 ]
Liew, A. [1 ,3 ,4 ]
机构：
[1] Galway Univ Hosp, Dept Med, Galway, Ireland
[2] Mercy Univ Hosp, Dept Med, Cork, Ireland
[3] Natl Univ Ireland Galway, Discipline Med, Galway, Ireland
[4] Portiuncula Univ Hosp, Dept Med, Galway, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2021年 / 190卷 / SUPPL 3期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P85
引用
收藏
页码：110 / 110
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of Glucagon-like peptide-1 receptor agonist (GLP-1RA) plus basal insulin versus basal insulin in Type 2 Diabetes Mellitus: A Systematic review and Meta-analysis
    Conboy, M.
    Houlihan, C.
    O'Brien, T.
    Liew, A.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S372 - S372
  • [2] Transitioning from basal-bolus or premix insulin therapy to a combination of basal insulin and glucagon-like peptide-1 receptor agonist in people with type 2 diabetes
    Mehta, Roopa
    Billings, Liana K.
    Liebl, Andreas
    Vilsboll, Tina
    [J]. DIABETIC MEDICINE, 2022, 39 (09)
  • [3] Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes
    Diamant, Michaela
    Nauck, Michael A.
    Shaginian, Rimma
    Malone, James K.
    Cleall, Simon
    Reaney, Matthew
    de Vries, Danielle
    Hoogwerf, Byron J.
    MacConell, Leigh
    Wolffenbuttel, Bruce H. R.
    [J]. DIABETES CARE, 2014, 37 (10) : 2763 - 2773
  • [4] GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes: A systematic review and meta-analysis
    Castellana, Marco
    Cignarelli, Angelo
    Brescia, Francesco
    Laviola, Luigi
    Giorgino, Francesco
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35 (01)
  • [5] Safety and efficacy of a glucagon-like peptide-1 receptor agonist added to basal insulin therapy versus basal insulin with or without a rapid-acting insulin in patients with type 2 diabetes: results of a meta-analysis
    Wysham, Carol H.
    Lin, Jay
    Kuritzky, Louis
    [J]. POSTGRADUATE MEDICINE, 2017, 129 (04) : 436 - 445
  • [6] A randomized trial comparing the efficacy and safety of treating patients with type 2 diabetes and highly elevated HbA1c levels with basal-bolus insulin or a glucagon-like peptide-1 receptor agonist plus basal-bolus insulin: The SIMPLE study
    Abreu, Marconi
    Tumyan, Anna
    Elhassan, Ahmed
    Peicher, Katherine
    Papacostea, Olivia
    Dimachkie, Perihan
    Siddiqui, Muhammad S.
    Pop, Laurentiu M.
    Gunasekaran, Uma
    Meneghini, Luigi F.
    Adams-Huet, Beverley
    Li, Xilong
    Lingvay, Ildiko
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (09): : 2133 - 2141
  • [7] Glucagon-like peptide-1 receptor agonist and basal insulin combination tre atment for the management of type 2 diabetes: a systematic review and meta-analysis
    Eng, Conrad
    Kramer, Caroline K.
    Zinman, Bernard
    Retnakaran, Ravi
    [J]. LANCET, 2014, 384 (9961): : 2228 - 2234
  • [8] Glucagon-like peptide-1 receptor agonist versus basal insulin in type-2 diabetic patients: An efficacy and safety analysis
    Lin, Kaiping
    Lv, Qi
    Yang, Xiaoling
    Lin, Ting
    Feng, Min
    Chen, Xiaxia
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2020, 19 (10) : 2213 - 2217
  • [9] The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials
    Maiorino, Maria Ida
    Chiodini, Paolo
    Bellastella, Giuseppe
    Scappaticcio, Lorenzo
    Longo, Miriam
    Giugliano, Dario
    Esposito, Katherine
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 154 : 101 - 115
  • [10] Glucagon-like Peptide-1 Receptor Agonists Versus Insulin Glargine for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Li, Wei-Xin
    Gou, Jian-Feng
    Tian, Jin-Hui
    Yan, Xiang
    Yang, Lin
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2010, 71 (04): : 211 - 238
12345